دورية أكاديمية

948TiP - Phase 3 study of quizartinib (AC220) monotherapy vs salvage chemotherapy (SC) in patients (pts) with FLT3-ITD+ acute myeloid leukemia (AML) refractory to or relapsed (R/R) after 1st-line treatment with or without hematopoietic stem cell transplant (HSCT) consolidation: the QuANTUM-R study

التفاصيل البيبلوغرافية
العنوان: 948TiP - Phase 3 study of quizartinib (AC220) monotherapy vs salvage chemotherapy (SC) in patients (pts) with FLT3-ITD+ acute myeloid leukemia (AML) refractory to or relapsed (R/R) after 1st-line treatment with or without hematopoietic stem cell transplant (HSCT) consolidation: the QuANTUM-R study
المؤلفون: Cortes, J., Gammon, G., Khaled, S., Martinelli, G., Kramer, A., Steffen, B., Hogge, D., Jonas, B.A., Dombret, H., Perl, A.
المصدر: In Annals of Oncology 1 October 2016 27 Supplement 6:vi327-vi327
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1093/annonc/mdw375.43